Paper
0
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
Authors
Martin Faßnacht,Alfredo Berruti
Éric Baudin,Michael Demeure,Jill Gilbert,Harm Haak,Matthias Kroiß,David Quinn,Elizabeth Hesseltine,Cristina Ronchi,Massimo Terzolo,Toni Choueiri,Srinivasu Poondru,Tanya Fleege,Ramona Rorig,Jihong Chen,Andrew Stephens,Francis Worden,Gary Hammer
+17 authors
,Martin FassnachtJournal
Published
Mar 23, 2015
Show more
Save
Tip0
TipSave